[5] There is essentially no risk of B-induced neuropathy at the doses used here, especially given the limited duration most patients use injectable therapy
Individuals with digestive system conditions including Crohns disease, celiac disease, or a history of gastrointestinal surgery often have difficulty absorbing B12 orally, regardless of diet
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
In those trials, many participants lost a significant percentage of body weight when combined with lifestyle changes
What is the AOD-9604 peptide and how does it affect the body
Ensuring proper reconstitution with Bacteriostatic Reconstitution Water (bac) is also essential for injectables
